Patents by Inventor Michael Hoey

Michael Hoey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130172867
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Another feature of the prostate therapy system is that it can aspirate tissue from the prostate. Yet another feature of the prostate therapy system is that it includes a cutter that can rotate during delivery of vapor and aspiration of tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Application
    Filed: February 27, 2013
    Publication date: July 4, 2013
    Inventors: John H. Shadduck, Michael Hoey
  • Publication number: 20130158534
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe from the urethra. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Another feature of the prostate therapy system is that it can aspirate tissue from the prostate. Yet another feature of the prostate therapy system is that it can rotate during delivery of vapor and aspiration of tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Application
    Filed: February 11, 2013
    Publication date: June 20, 2013
    Inventors: Michael Hoey, John H. Shadduck
  • Patent number: 8444636
    Abstract: An instrument for thermally-mediated therapies in targeted tissue volumes or for volumetric removal of tissue. In one embodiment, the instrument has an interior chamber that includes a diffuser structure for diffusing a biocompatible conductive fluid that is introduced under high pressure. The interior chamber further includes surfaces of opposing polarity electrodes for vaporizing the small cross-section diffused fluid flows created within a diffuser structure. In one embodiment, the diffuser structure includes a negative temperature coefficient of resistance material between the opposing polarity surfaces. The NTCR structure can self-adjust the lengths of current paths between the opposing polarities to insure complete vaporization of the volume of flow of conductive fluid.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: May 21, 2013
    Assignee: Tsunami MedTech, LLC
    Inventors: John H. Shadduck, Michael Hoey
  • Publication number: 20130116683
    Abstract: Medical instruments and systems for applying energy to tissue, and more particularly relates to systems for ablating or damaging structures in a body or vessel wall to alter electrical conduction therein to cause an intended therapeutic effect. Variations include devices and methods for generating a high pressure flow of a liquid media and/or a vapor media to treat the targeted tissue by the application of mechanical energy, thermal energy or chemical energy to such targeted tissue.
    Type: Application
    Filed: November 9, 2011
    Publication date: May 9, 2013
    Applicant: TSUNAMI MEDTECH, LLC
    Inventors: John H. SHADDUCK, Michael HOEY
  • Patent number: 8419723
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Another feature of the prostate therapy system is that it can aspirate tissue from the prostate. Yet another feature of the prostate therapy system is that it can rotate during delivery of vapor and aspiration of tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: April 16, 2013
    Assignee: NxThera, Inc.
    Inventors: John H. Shadduck, Michael Hoey
  • Publication number: 20130087468
    Abstract: Mastitis in a milking animal is detected through sensing the capacitance effects in milk. Using frequencies of greater than 60 megahertz applied by a capacitance probe to milk as it streams through otherwise conventional milking equipment during milking, yields a reliably discernable shift in the phase angle, indicating the presence of mastitis.
    Type: Application
    Filed: October 8, 2012
    Publication date: April 11, 2013
    Inventor: Michael Hoey
  • Patent number: 8388611
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Another feature of the prostate therapy system is that it can aspirate tissue from the prostate. Yet another feature of the prostate therapy system is that it includes a cutter that can rotate during delivery of vapor and aspiration of tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: March 5, 2013
    Assignee: NxThera, Inc.
    Inventors: John H. Shadduck, Michael Hoey
  • Patent number: 8372065
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe from the urethra. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Another feature of the prostate therapy system is that it can aspirate tissue from the prostate. Yet another feature of the prostate therapy system is that it can rotate during delivery of vapor and aspiration of tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: February 12, 2013
    Assignee: NxThera, Inc.
    Inventors: Michael Hoey, John H. Shadduck
  • Publication number: 20120323167
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 20, 2012
    Inventors: Michael Hoey, John H. Shadduck
  • Publication number: 20120271300
    Abstract: An instrument for thermally-mediated therapies in targeted tissue volumes or for volumetric removal of tissue. In one embodiment, the instrument has an interior chamber that includes a diffuser structure for diffusing a biocompatible conductive fluid that is introduced under high pressure. The interior chamber further includes surfaces of opposing polarity electrodes for vaporizing the small cross-section diffused fluid flows created within a diffuser structure. In one embodiment, the diffuser structure includes a negative temperature coefficient of resistance material between the opposing polarity surfaces. The NTCR structure can self-adjust the lengths of current paths between the opposing polarities to insure complete vaporization of the volume of flow of conductive fluid.
    Type: Application
    Filed: January 10, 2006
    Publication date: October 25, 2012
    Inventors: John Shadduck, Michael Hoey
  • Publication number: 20120259271
    Abstract: Methods and devices for delivering energy to lung tissue, for example to cause lung volume reduction by generating a flow of vapor and introducing the flow of vapor into the lung where the vapor delivers thermal energy sufficient to modify lung tissue.
    Type: Application
    Filed: March 14, 2012
    Publication date: October 11, 2012
    Applicant: TSUNAMI MEDTECH, LLC
    Inventors: John H. SHADDUCK, Michael HOEY
  • Patent number: 8273079
    Abstract: A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the needle can ablate a continuous lobe region in the prostate parallel to the urethral wall. Another feature of the vapor delivery needle is that it can introduce a cooling fluid into the urethra during treatment. Methods associated with use of the energy delivery probe are also covered.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: September 25, 2012
    Assignee: NxThera, Inc.
    Inventors: Michael Hoey, Mark Schrom, Stephanos Paulos, Randall Beyreis
  • Patent number: 8272383
    Abstract: An energy delivery probe is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply energy to tissue, such as a duct, to shrink, damage, or occlude the duct. In some embodiments, the energy can be applied with a vapor media. In some embodiments, the duct can be a ductus deferens or an ejaculatory duct of the male reproductive system. Another feature of the energy delivery probe is that it can utilize an inflatable member to form a seal to contain the vapor media. Methods associated with use of the energy delivery probe are also covered.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: September 25, 2012
    Assignee: NxThera, Inc.
    Inventors: Michael Hoey, John H. Shadduck
  • Patent number: 8251985
    Abstract: A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: August 28, 2012
    Assignee: NxThera, Inc.
    Inventors: Michael Hoey, John H. Shadduck
  • Patent number: 8187269
    Abstract: A surgical instrument for delivering energy to lung tissue, for example to cause lung volume reduction. In one embodiment, an elongated catheter has a handle portion that includes an interior chamber that is supplied with a biocompatible liquid media under pressure. An energy source delivers energy to the media to cause a liquid-to-vapor phase change within the interior chamber and ejects a flow of vapor media from the working end of the catheter. The delivery of energy and the flow of vapor are controlled by a computer controller to cause a selected pressure and selected volume of vapor to propagate to the extremities of the airways. Contemporaneously, the vapor undergoes a vapor-to-liquid phase transition which delivers large amount of energy to the airway tissue. The thermal energy delivered is equivalent to the heat of vaporization of the fluid media, which shrinks and collapses the treated airways.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: May 29, 2012
    Assignee: Tsunami MedTech, LLC
    Inventors: John H. Shadduck, Michael Hoey
  • Publication number: 20120116376
    Abstract: A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the needle can ablate a continuous lobe region in the prostate parallel to the urethral wall. Another feature of the vapor delivery needle is that it can introduce a cooling fluid into the urethra during treatment. Methods associated with use of the energy delivery probe are also covered.
    Type: Application
    Filed: January 17, 2012
    Publication date: May 10, 2012
    Inventors: Michael Hoey, Mark Schrom, Stephanos Paulos, Randall Beyreis
  • Publication number: 20120035088
    Abstract: The instant invention provides a lubricant composition having improved four-ball antiwear properties. The lubricant composition includes a base oil and one or more alkylethercarboxylic acid corrosion inhibitor(s) having the formula: wherein R is a straight or branched chain C6-C18 alkyl group and n is a number of from 0 to 5. The lubricant composition also includes an ashless antiwear additive including phosphorous. The four-ball antiwear properties are reported as an average diameter of wear scars pursuant to ASTM D4172. The average diameter of the wear scars resulting from the lubricant composition are at least 5% smaller than the average diameter of the wear scars resulting from a standard that includes the base oil and the antiwear additive and that is free of the one or more alkylethercarboxylic acid corrosion inhibitor(s).
    Type: Application
    Filed: July 13, 2011
    Publication date: February 9, 2012
    Inventors: Philippe Marc Andre Rabbat, Ryan James Fenton, David Eliezer Chasan, Kevin J. DeSantis, Michael Hoey, Eugene Scanlon
  • Patent number: 8090436
    Abstract: A system and method for discriminating tissue types, controlling the level of therapy to tissue, and determining the health of a known tissue by measuring the characteristics of an electrical signal applied to a conductive element located within or by the tissue. Additionally, the system and method may be used for determining whether the conductive tip of a pedicle probe or pedicle screw is located in one of cortical bone, cancellous bone, and cortical bone near a boundary with soft tissue, whether the conductive tip of a cannula is located adjacent to one of nerve tissue and annulus tissue, and whether the conductive tip of a cathode is located adjacent to one of nerve tissue and prostate gland tissue.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: January 3, 2012
    Assignee: NuVasive, Inc.
    Inventors: Michael Hoey, Corbett Stone, Kevin Foley
  • Publication number: 20110313312
    Abstract: A system and method for discriminating tissue types, controlling the level of therapy to tissue, and determining the health of a known tissue by measuring the characteristics of an electrical signal applied to a conductive element located within or by the tissue. Additionally, the system and method may be used for determining whether the conductive tip of a pedicle probe or pedicle screw is located in one of cortical bone, cancellous bone, and cortical bone near a boundary with soft tissue, whether the conductive tip of a cannula is located adjacent to one of nerve tissue and annulus tissue, and whether the conductive tip of a cathode is located adjacent to one of nerve tissue and prostate gland tissue.
    Type: Application
    Filed: August 30, 2011
    Publication date: December 22, 2011
    Applicant: NUVASIVE, INC.
    Inventors: Michael Hoey, Corbett W. Stone, Kevin Foley
  • Publication number: 20110264090
    Abstract: A surgical instrument for delivering energy to lung tissue, for example to cause lung volume reduction. In one embodiment, an elongated catheter has a handle portion that includes an interior chamber that is supplied with a biocompatible liquid media under pressure. An energy source delivers energy to the media to cause a liquid-to-vapor phase change within the interior chamber and ejects a flow of vapor media from the working end of the catheter. The delivery of energy and the flow of vapor are controlled by a computer controller to cause a selected pressure and selected volume of vapor to propagate to the extremities of the airways. Contemporaneously, the vapor undergoes a vapor-to-liquid phase transition which delivers large amount of energy to the airway tissue. The thermal energy delivered is equivalent to the heat of vaporization of the fluid media, which shrinks and collapses the treated airways.
    Type: Application
    Filed: November 16, 2010
    Publication date: October 27, 2011
    Applicant: TSUNAMI MEDTECH, LLC
    Inventors: John H. SHADDUCK, Michael HOEY